GCTKNCMHealthcare·Medical Instruments & Supplies#58 in industry

GlucoTrack, Inc.

-79.0% · 90d

$0.72

-0.02 (-2.44%)

News

(1)

March 2026

Mar 30, 20260 months ago8-KHealthcare

Glucotrack, Inc. — 8-K Filing

GCTKGlucotrack, Inc.

# 🧾 What This Document Is This is Glucotrack's **earnings release for the full year 2025**, combined with major company news. It's an 8-K filing, which companies use to announce important events to investors. Here, they're telling us how much money they made and lost, while also highlighting big st

Read summaryView on SEC EDGAR

Key Data

Market Cap$1.4M

Open$0.72

Prev Close$0.73

Day Range$0.70 – $0.73

52W Range$0.62 – $15.90

Volume102,397

P/E (TTM)—

EPS$-31.22

Dividend Yield—

Beta0.61

About

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Healthcare · Medical Instruments & Supplies

glucotrack.com